Opcjonalna analityka produktu
Za zgodą użytkownika stosujemy ograniczoną analitykę chroniącą prywatność, aby zrozumieć, które ścieżki badawcze działają. Nie używamy trackerów reklamowych ani nagrywania sesji. Ten wybór można zmienić w Preferencjach. Przeczytaj Politykę prywatności.
Apple Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.67T | |
|---|---|---|
| Revenue (ttm) | 466.8B | |
| Net income (ttm) | 128.9B | |
| EPS (ttm) | $8.72 | |
| Shares out | 14.6B | |
| P/E (trailing) | 39.4x | |
| P/E (forward) | 33.6x | |
| Dividend | $1.08 (0.31%) | |
| Volume | 20,920,297 | |
| Beta | 1.07 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-09-25 | 2022-09-24 | 2023-09-30 | 2024-09-28 | 2025-09-27 | Trend |
| Revenue | $365.82B | $394.33B | $383.29B | $391.04B | $416.16B | +3.3% |
| Gross profit | $152.84B | $170.78B | $169.15B | $180.68B | $195.20B | +6.3% |
| Operating income | $108.95B | $119.44B | $114.30B | $123.22B | $133.05B | +5.1% |
| Net income | $94.68B | $99.80B | $97.00B | $93.74B | $112.01B | +4.3% |
| EPS (diluted) | $5.61 | $6.11 | $6.13 | $6.08 | $7.46 | +7.4% |
| EBITDA | $123.14B | $130.54B | $125.82B | $134.66B | $144.43B | +4.1% |
| R&D | $21.91B | $26.25B | $29.92B | $31.37B | $34.55B | +12.1% |
| SG&A | $21.97B | $25.09B | $24.93B | $26.10B | $27.60B | +5.9% |
Recent company headlines from major financial publishers.
The Base path assumes near-term demand converts, followed by slower mature growth. Sustained stronger growth or a material undershoot would disconfirm that path.
This scenario requires improved availability to convert demand into revenue and continued share reduction to support earnings per share. It fails if FY2027 revenue growth falls below 8%, or if diluted shares stop falling.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 6.9% | $251 | $263 | $278 | $298 | $324 |
| 7.9% | $223 | $231 | $240 | $251 | $266 |
| 8.9% | $203 | $208 | $214 | $221 | $230 |
| 9.9% | $187 | $191 | $195 | $200 | $206 |
| 10.9% | $175 | $177 | $181 | $184 | $188 |
Upcoming earnings date and setup when available.
Rekomendacja, którą nosiło opublikowane w danym miesiącu wydanie analizy. Rekomendacja porównuje cenę z dnia analizy z wartością godziwą; nie jest zapisem tego, czy ocena się sprawdziła.
| Rok | sty | lut | mar | kwi | maj | cze | lip | sie | wrz | paź | lis | gru |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |